Aria Diagnostics Obtains $52,700,000 Series C Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3df2370b-c5ec-4635-9504-a41d1d6fcab8&Preview=1
Date
1/10/2012
Company Name
Aria Diagnostics
Mailing Address
5945 Optical Court San Jose, CA 95138
Company Description
Aria Diagnostics is a privately funded biotechnology company based on a strong scientific foundation. Our novel blood tests equip pregnant women with the right information to make decisions regarding the health of their baby and their own body.
Website
http://www.ariadx.com
Transaction Type
Venture Equity
Transaction Amount
$52,700,000
Transaction Round
Series C
Proceeds Purposes
Aria will use the funds to support product development and prepare commercialization of its proprietary prenatal test to detect common fetal trisomies such as Trisomy 21, which is associated with Down syndrome.
M&A Terms
Venture Investor
Meritech Capital Partners
Venture Investor
Venrock
Venture Investor
Domain Associates